Lyell Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
CB
Lyell Wealth Management's IBB Position: Q2 2026 in Review
Lyell Wealth Management increased its iShares Biotechnology ETF (IBB) stake by 11% in Q2 2026, buying an estimated $340K and bringing the position to 19,548 shares worth $3.72M. The position accounts for 0.23% of the portfolio, ranked #76.
Lyell Wealth Management first reported a position in IBB in Q3 2021 and has held it in 18 quarters since. 957 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Lyell Wealth Management held 19,548 shares of iShares Biotechnology ETF worth $3.72M as of Q2 2026.
- Lyell Wealth Management bought 1,978 iShares Biotechnology ETF shares in Q2 2026, an estimated $340K.
- iShares Biotechnology ETF made up 0.23% of Lyell Wealth Management's portfolio in Q2 2026, its #76 holding.
- Lyell Wealth Management first reported a position in iShares Biotechnology ETF in Q3 2021 and has held it in 18 quarters since.
- 957 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Lyell Wealth Management's 13F filing for Q2 2026, filed 5 Aug 2026.